Search

Past literature on prosocial behavior in aging has mainly focused on age-related differences. However, the analysis of the predictors of prosociality in late adulthood is still under investigated. The present study examines how personality traits predict actual and self-reported prosocial behaviors, while considering the mediation effects of empathic concern and the moderator effect of age, in an Italian sample of 150 participants aged from 55 to 86 years old (M age = 69.52). Based on a path analysis model, results revealed that agreeableness has a direct association with self-reported prosocial behavior and an indirect relationship, via empathic concern, with actual prosocial behavior. In addition, emotional stability further explains variations in older adults' prosociality, via empathic concern. Age also plays a different role on actual and self-reported behaviors. While the relationship between empathic concern and actual behavior is the same in middle-aged and older adults, in the self-reported behaviors it changes according to the age of participants. As they grow older, people perform prosocial acts in daily life driven by basic dispositions, such as agreeableness, and not by empathic concern. These findings have important implications regarding the understanding of the motives that drive the different prosocial behaviors in the older population. [ABSTRACT FROM AUTHOR]

Reciprocity is a fundamental element in social interactions and implies an adequate response to the previous actions of our interactant. It is thus crucial to detect if a person is cooperating, deceiving, or cheating, to properly respond. However, older adults have been shown to have a lower ability to detect reciprocity compared to younger adults, partially tying this decline to cognitive functions. Another likely association to reciprocity in literature is made with personality dispositions, i.e., agreeableness, altruism, and empathic concern, and Theory of Mind (ToM). Consequently, the present study investigated age-related differences in the detection of the different components of reciprocity, as well as examined the predictors of reciprocity, such as cognitive measures, personality dispositions, and true and false beliefs in young (n = 98; 20–39 years), middle-aged (n = 106; 40–64 years), and older adults (n = 103; 65–96 years). The Mind Picture Story-Theory of Mind Questionnaire was used to measure the reciprocity components and true and false beliefs in each group. This study reported a significant decline in reciprocity detection from adults aged 65 years old and over. Additionally, the ability to detect reciprocity was significantly linked to cognitive functioning and ToM across all age groups, especially in older adults. [ABSTRACT FROM AUTHOR]

Background: A specific evaluation of the capacity to consent to research in older adults with cognitive decline is often not included routinely in research practice. However, there is a need to evaluate this competence adopting brief standardized instruments to guarantee their ethical rights. The present study evaluated in older adults with normal cognitive functioning, and major and mild neurocognitive disorders whether the Mini-Mental State Examination (MMSE) and a brief battery of neuropsychological tests are sensitive and specific to discriminate subjects able to provide consent to research. Methods: 54 participants with Major Neurocognitive Disorder (MajorNCD), 22 with Mild Neurocognitive Disorder (MildNCD), and 37 Normal Cognitive Functioning individuals (NCF). The capacity to provide consent was assessed using the MacArthur Competence Assessment Tool for Clinical Research. Cognitive functioning was assessed using the MMSE, Verbal Fluency Tests, Trail Making Test (TMT-A), Immediate and Delayed Recall Test. Results: In the MildNCD and NCF groups, the aggregate score of neuropsychological tests showed high sensitivity and specificity in classifying subjects able to provide consent to research. In the MajorNCD group, MMSE, Recall test, and TMT-A performed better than the aggregate score in classifying subjects as able of consenting to the hypothetical research. Conclusion: The choice of the best tool to assess the ability to provide consent to research may depend on the degree of cognitive impairment. MMSE is a good tool for subjects with MajorNCD. A more comprehensive battery of neuropsychological tests would represent a better tool in NCF and MildNCD individuals. [ABSTRACT FROM AUTHOR]

• NT-proBNP is a sensible and specific marker of heart failure, and its plasma levels also increase with age. The mortality predictive value of NT-proBNP in patients without heart failure, especially older adults, is less established. • In the present study of patients with type 2 diabetes mellitus stabilised after an ACS, elevated NT-proBNP levels are the most powerful predictor of all-cause and cardiovascular mortality across age categories, and its predictive information does not tend to decrease with age. • This information should inform treatment strategies and future practice Guidelines. To assess the impact of age on the prognostic value of NT-proBNP concentration in patients with type-2 diabetes mellitus (T2DM) stabilised after an Acute Coronary Syndrome (ACS). The AleCardio study compared aleglitazar with placebo in 7226 patients with T2DM and recent ACS. Patients with heart failure were excluded. Median follow-up was 104 weeks. Baseline NT-proBNP plasma concentration was measured centrally. Multivariable Cox regression was used to determine the mortality predictive information provided by NT-proBNP across age groups. Median age was 61y (IQR 54, 67). NT-proBNP concentration increased by quartile (Q) of age (median 264, 318, 391, and 588 pg/ml). Compared to Q1, patients in Q4 of NT-proBNP had higher (p < 0.001) adjusted HR for all-cause (aHR 6.9; 95 % CI 4.0–12) and cardiovascular (11; 5.4–23) death. Within each age Q, baseline NT-proBNP in patients who died was 3 times higher than in survivors (all p < 0.001). When age and NT-proBNP levels were modeled as continuous variables, their interaction term was nonsignificant. The relative prognostic information provided by NT-proBNP (percent of total X2) increased from 38 % in age Q1 to 75 % in age Q4 for mortality, and from 50 % to 88 % for CV death. Among patients with T2DM stabilised after an ACS, NT-proBNP level predicts death irrespective of age. [ABSTRACT FROM AUTHOR]